DDX41 mutations in patients with non-myeloid hematologic neoplasms

Am J Hematol. 2023 Aug;98(8):E193-E196. doi: 10.1002/ajh.26952. Epub 2023 May 8.

Authors

Fatima Zahra Jelloul¹, Mark J Routbort¹, Courtney D DiNardo², Carlos E Bueso-Ramos¹, Rashmi Kanagal-Shamanna¹, Beenu Thakral¹, Zhuang Zuo¹, C Cameron Yin¹, Sanam Loghavi¹, Chi Young Ok¹, Sa A Wang¹, Zhenya Tang¹, M James You¹, Keyur P Patel¹, L Jeffrey Medeiros¹, Andrés E Quesada¹

Affiliations

¹ Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
² Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

PMID: 37154083
DOI: 10.1002/ajh.26952

No abstract available

Publication types

Letter

MeSH terms

DEAD-box RNA Helicases / genetics
Hematologic Neoplasms* / genetics
Humans
Leukemia, Myeloid, Acute* / genetics
Mutation

Substances

DDX41 protein, human
DEAD-box RNA Helicases